Market Overview

The Global Digital Biomarkers Market was valued at USD 3,634.1 million in 2023 and is expected to reach USD 18,189.2 million by 2031 while growing at a CAGR of 22.3% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global digital biomarkers market growth. Digital biomarkers, collected through devices like wearables and smartphones, are measurable indicators of biological processes. They offer objective data on health, behaviors, or disease progression, distinguishing them from traditional biomarkers obtained through blood tests or imaging studies.

Advancements in wearable devices, sensors, and mobile health apps, along with the increasing prevalence of chronic diseases like cardiovascular disorders, diabetes, and respiratory conditions, are driving the digital biomarkers market. However, challenges such as privacy and data security concerns, as well as a lack of standardization in digital biomarker development, may impede market growth.

Furthermore, the global digital biomarkers industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Digital Biomarkers Market is segmented among Data Collection Tools, and Data Integration Tools, based on type. In 2023, Data Integration Tools accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Clinical Practice Analysis

The Global Digital Biomarkers Market is segmented among Monitoring Digital Biomarkers, Diagnostic Digital Biomarkers, Predictive and Prognostic Digital Biomarkers, and Others, based on Clinical Practice. In 2023, Monitoring Digital Biomarkers accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Digital Biomarkers Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Akili, Inc., ActiGraph, LLC., AliveCor, Inc., Fitbit Health Solutions, Empatica Inc., Biogen, F. Hoffmann-La Roche Ltd., Koneksa, IXICO plc, and Huma.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Digital Biomarkers Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Digital Biomarkers Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Digital Biomarkers Market Segmentation, By Type

• Global Digital Biomarkers Market Share Analysis, By Type

• Global Digital Biomarkers Market Growth Analysis, By Type

• Global Digital Biomarkers Market Trends, By Type

o Data Collection Tools

o Data Integration Tools

6. Global Digital Biomarkers Market Segmentation, By Clinical Practice

• Global Digital Biomarkers Market Share Analysis, By Clinical Practice

• Global Digital Biomarkers Market Growth Analysis, By Clinical Practice

• Global Digital Biomarkers Market Trends, By Clinical Practice

o Monitoring Digital Biomarkers

o Diagnostic Digital Biomarkers

o Predictive and Prognostic Digital Biomarkers

o Others

7. Global Digital Biomarkers Market Segmentation, By Therapeutic Area

• Global Digital Biomarkers Market Share Analysis, By Therapeutic Area

• Global Digital Biomarkers Market Growth Analysis, By Therapeutic Area

• Global Digital Biomarkers Market Trends, By Therapeutic Area

o Cardiovascular and Metabolic Disorders

o Respiratory Disorders

o Neurological Disorders

o Musculoskeletal Disorders

o Others

8. Global Digital Biomarkers Market Segmentation, By End User

• Global Digital Biomarkers Market Share Analysis, By End User

• Global Digital Biomarkers Market Growth Analysis, By End User

• Global Digital Biomarkers Market Trends, By End User

o Pharmaceutical Companies

o Healthcare Providers

o Payers

o Others

9. Global Digital Biomarkers Market Segmentation, By Region

• Global Digital Biomarkers Market Share Analysis, By Region

• Global Digital Biomarkers Market Growth Analysis, By Region

• Global Digital Biomarkers Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

• Akili, Inc*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• ActiGraph, LLC.

• AliveCor, Inc.

• Fitbit Health Solutions

• Empatica Inc.

• Biogen

• F. Hoffmann-La Roche Ltd.

• Koneksa

• IXICO plc

• Huma

*Similar analysis will be provided for each company listed above.